XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity - Additional Information (Detail)
1 Months Ended 9 Months Ended
Aug. 15, 2023
USD ($)
shares
Sep. 27, 2022
USD ($)
$ / shares
shares
Apr. 06, 2022
USD ($)
$ / shares
shares
Oct. 18, 2021
USD ($)
PrivatePlacement
$ / shares
shares
Oct. 05, 2021
USD ($)
$ / shares
shares
Oct. 31, 2024
USD ($)
shares
Feb. 29, 2024
shares
Jun. 30, 2023
USD ($)
May 31, 2022
USD ($)
Oct. 31, 2021
PrivatePlacement
Jun. 30, 2020
USD ($)
Sep. 30, 2024
USD ($)
shares
Stockholders Equity [Line Items]                        
Share based compensation options grants in the period                       3,396,750
Performance-Based Vesting Stock Options [Member]                        
Stockholders Equity [Line Items]                        
Share based compensation options grants in the period             832,250          
Private Placement [Member]                        
Stockholders Equity [Line Items]                        
Number of private placements | PrivatePlacement                   2    
Private Placement [Member] | Investor [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock         9,852,138              
Warrants Exercised         1,299,270              
Warrants expiration date         Oct. 05, 2028              
Private Placement [Member] | Investor [Member] | Common Stock [Member]                        
Stockholders Equity [Line Items]                        
Sale of stock during the period         2,373,201              
Warrants to purchase aggregate shares of common stock         4,746,402              
Private Placement [Member] | Investor [Member] | Pre-funded Warrants [Member]                        
Stockholders Equity [Line Items]                        
Exercise price per share of warrants | $ / shares         $ 0.001              
Private Placement [Member] | Investor [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                        
Stockholders Equity [Line Items]                        
Combined price of each shares | $ / shares         1.62              
Private Placement [Member] | Investor [Member] | Pre-funded Warrant and Accompanying Common Stock Warrants [Member]                        
Stockholders Equity [Line Items]                        
Combined price of each shares | $ / shares         $ 1.619              
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $         $ 11,800,000              
Private Placement [Member] | Investor [Member] | Common Stock Warrants                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock         7,299,270              
Exercise price per share of warrants | $ / shares         $ 1.37              
Warrants expiration date         Apr. 05, 2025              
Private Placement [Member] | Investor [Member] | Warrant [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock         7,299,270              
Warrants expiration date         Oct. 05, 2028              
Private Placement [Member] | New Enterprise Associates 16, L.P [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock       3,703,704                
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $       $ 13,700,000                
Number of private placements | PrivatePlacement       2                
Proceeds from issuance of private placement net of issuance costs | $       $ 1,100,000                
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock [Member]                        
Stockholders Equity [Line Items]                        
Sale of stock during the period       1,851,852                
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock and Accompanying Common Stock Warrants [Member]                        
Stockholders Equity [Line Items]                        
Common stock warrants exercise price and expiration date description                       The accompanying common stock warrants have an exercise price of $1.37 per share and became exercisable immediately upon issuance. Of the accompanying common stock warrants, warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock will expire on April 18, 2025, and warrants to purchase an aggregate of 1,851,852 shares of the Company’s common stock will expire on October 18, 2028. None of the accompanying common stock warrants issued to NEA in the private placement have been exercised.
Combined price of each shares | $ / shares       $ 1.62                
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $       $ 3,000,000                
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Common Stock Warrants                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock       1,851,852                
Exercise price per share of warrants | $ / shares       $ 1.37                
Warrants expiration date       Apr. 18, 2025                
Private Placement [Member] | New Enterprise Associates 16, L.P [Member] | Warrant [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock       1,851,852                
Warrants expiration date       Oct. 18, 2028                
Private Placement [Member] | Securities Purchase Agreement [Member] | Common Stock [Member]                        
Stockholders Equity [Line Items]                        
Sale of stock during the period     4,580,526                  
Combined price of each shares | $ / shares     $ 1.90                  
Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                        
Stockholders Equity [Line Items]                        
Combined price of each shares | $ / shares     $ 1.899                  
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $     $ 55,000,000                  
Exercise price per share of warrants | $ / shares     $ 0.001                  
September 2022 Offering [Member] | Underwriting Agreement [Member]                        
Stockholders Equity [Line Items]                        
Proceeds from sale of common stock and warrants under public and private placements, net of issuance costs | $   $ 58,100,000                    
Warrants expiration date   Sep. 27, 2022                    
September 2022 Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]                        
Stockholders Equity [Line Items]                        
Sale of stock during the period   14,252,670                    
Combined price of each shares | $ / shares   $ 1.93                    
Exercise price per share of warrants | $ / shares   $ 0.001                    
September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock   14,247,330                    
Combined price of each shares | $ / shares   $ 1.929                    
Options to purchase additional shares   1,600,428                    
Maximum [Member] | Private Placement [Member] | Investor [Member] | Pre-funded Warrants [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock         4,926,069              
Maximum [Member] | Private Placement [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock     24,379,673                  
Maximum [Member] | September 2022 Offering [Member] | Underwriting Agreement [Member] | Pre-funded Warrants [Member]                        
Stockholders Equity [Line Items]                        
Warrants to purchase aggregate shares of common stock   4,275,000                    
ATM Sales Agreement [Member]                        
Stockholders Equity [Line Items]                        
Aggregate offering price of common stock which may issue and sell under agreement | $               $ 75,000,000 $ 50,000,000   $ 12,000,000 $ 62,000,000
Sale of stock during the period 4,333,394                     3,086,729
Proceeds from issuance of common stock | $ $ 12,700,000                     $ 10,000,000
Estimated commissions and allocated fees | $ $ 1,000,000                     $ 300,000
Proceeds from issuance of common stock, preferred stock, debt securities, units and or warrants | $               $ 200,000,000        
Subsequent Event [Member] | ATM Sales Agreement [Member]                        
Stockholders Equity [Line Items]                        
Sale of stock during the period           1,411,336            
Proceeds from issuance of common stock | $           $ 4,600,000            
Estimated commissions and allocated fees | $           $ 100,000